Argentina approves AstraZeneca-Oxford COVID-19 vaccine


Argentina is the second country to approve the AstraZeneca-Oxford Covid vaccine (file)

Buenos Aires:

Argentina has followed the UK and became the second country to approve the coronavirus vaccine developed by drug company AstraZeneca and Oxford University, the government said on Wednesday.

Argentina has signed a manufacturing agreement for the vaccine, which has been on an emergency registry for a year, the national drug administration said.

“The product offers an acceptable risk-benefit ratio,” the administration said in a statement.

The vaccine can be stored, transported and handled under normal refrigeration conditions and is therefore cheaper and easier to administer than other stings developed by Pfizer / BioNTech and Moderna that require freezing.

Argentina and Mexico have reached an agreement to manufacture and distribute the vaccine in Latin America.

It is the third Covid vaccine approved in Argentina after the Pfizer / BioNTech and Russian Sputnik V vaccinations.

The South American country started administering Sputnik V on Tuesday, which has come under fire for lack of clinical studies.


Argentina has acquired 300,000 cans of Sputnik V, with another 19 million expected to arrive in January and February.

However, the government has not yet reached an agreement with US pharmaceutical giant Pfizer to purchase its vaccine.

Argentina has recorded more than 43,000 deaths and over 1.6 million cases of the coronavirus among its 44 million people.

President Alberto Fernandez’s government has announced that it will buy a total of 51 million doses of vaccine.

(Except for the headline, this story was not edited by GossipMantri staff and posted from a syndicated feed.)


Please enter your comment!
Please enter your name here